Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology

Do I Need a Movement Disorder Specialist for Parkinson's?

At a Glance

A Movement Disorder Specialist (MDS) has advanced fellowship training in Parkinson's disease beyond what a general neurologist receives. Seeing an MDS can improve diagnostic accuracy, optimize complex medication regimens, and provide access to advanced therapies, often through telemedicine.

If you already have a general neurologist whom you trust, you might wonder whether it is truly necessary to travel to see a Movement Disorder Specialist (MDS) for your Parkinson’s disease. The short answer is that while a general neurologist can diagnose and manage early Parkinson’s disease, an MDS brings specialized training and experience that can significantly improve your diagnostic accuracy, optimize your medication regimen, and provide access to advanced treatments [1][2]. For patients who live far from specialized centers, telemedicine has emerged as a highly effective and convenient way to access this expertise without the burden of travel [3][4].

The Difference in Training

To understand the value of an MDS, it helps to look at their training. A general neurologist completes a four-year residency learning to diagnose and treat all conditions affecting the brain and nervous system, from strokes and migraines to Alzheimer’s and multiple sclerosis.

A Movement Disorder Specialist is a neurologist who has completed an additional fellowship program, typically lasting one to two years [1][5]. This fellowship focuses entirely on conditions like Parkinson’s disease, dystonia, and essential tremor [6][7]. Because they spend their fellowship and their subsequent careers focused on this specific group of diseases, they have deep expertise in the subtle nuances of Parkinson’s disease.

Why See a Specialist?

Research demonstrates several concrete benefits of seeing a Movement Disorder Specialist:

  • Improved Diagnostic Accuracy: Parkinson’s disease can be difficult to diagnose, especially in its early stages. Studies show that care by an MDS is associated with better diagnostic accuracy and more appropriate use of advanced diagnostic tools, such as DaTscans (a specialized type of brain imaging used to help confirm the diagnosis) [1][8].
  • Optimized Medication Management: As Parkinson’s progresses, managing medications becomes increasingly complex. You may experience motor fluctuations (periods where the medication wears off before your next dose) or dyskinesia (involuntary, erratic movements). MDS are highly experienced in fine-tuning complex medication regimens to minimize these issues [7][9]. They are also skilled at managing non-motor symptoms, such as sleep disturbances, blood pressure drops, and cognitive changes [10][11].
  • Access to Advanced Therapies: When oral medications are no longer sufficient, an MDS is trained to identify when you might be eligible for device-aided therapies [12][13]. These include deep brain stimulation (DBS) and continuous intestinal infusion therapies (such as the continuous delivery of levodopa medication) [14][15]. Guidelines emphasize that general neurologists should refer patients to specialized centers for these interventions, as early referral can improve clinical outcomes and quality of life [16][17].

Telemedicine: A Solution for Travel Barriers

The primary reason many people do not see an MDS is the distance and travel time required to reach a specialized center. However, telemedicine has become a widely adopted, feasible, and effective model for delivering specialized Parkinson’s care [3][18][10].

During a secure video appointment, an MDS can still evaluate your symptoms. While they cannot physically touch you to test muscle rigidity, they will often have you or a caregiver position the camera while you perform specific movements, like walking, finger tapping, or standing up from a chair. Patients consistently report high satisfaction with virtual care, valuing the convenience, time savings, and reduced need for travel while still receiving high-level specialty expertise [4][19][20].

If travel is a concern, you do not necessarily need to completely replace your local neurologist. Often, an MDS can act as a consultant via telemedicine, working collaboratively with your local neurologist who continues to manage your day-to-day care [10][21]. You can start this conversation with your current doctor by simply saying, “I value our relationship, but my daily symptoms are getting harder to manage. Would you be open to consulting with an MDS via telehealth?” Keep in mind that telemedicine availability may depend on state medical licensing rules and insurance coverage, so it is helpful to check with the specialist’s office beforehand.

Common questions in this guide

What is the difference between a general neurologist and a Movement Disorder Specialist?
A Movement Disorder Specialist is a neurologist who has completed an additional one to two years of fellowship training focused entirely on conditions like Parkinson's disease, dystonia, and essential tremor.
Can a general neurologist treat Parkinson's disease?
Yes, a general neurologist is fully trained to diagnose and manage early Parkinson's disease. However, as the disease progresses and medication management becomes more complicated, transitioning to or consulting with a specialist is often recommended.
When should I see a Movement Disorder Specialist for Parkinson's?
You should consider seeing a specialist if you experience complex symptoms such as your medication wearing off between doses, involuntary erratic movements, or if you are exploring advanced treatments like Deep Brain Stimulation.
Can I see a Movement Disorder Specialist via telehealth?
Yes, telemedicine is a highly effective way to see a specialist, especially if you live far from a specialty center. Through secure video appointments, a specialist can evaluate your movements, adjust medications, and consult with your local doctor.
Do I have to switch doctors to see a Movement Disorder Specialist?
Not necessarily. Many Movement Disorder Specialists act as consultants via telemedicine. They can work collaboratively with your local neurologist, who will continue to manage your day-to-day care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are you comfortable collaborating with a Movement Disorder Specialist to co-manage my Parkinson's disease?
  2. 2.At what point in my disease progression would you recommend I be evaluated by a Movement Disorder Specialist?
  3. 3.Do you use specific screening tools to determine if I am a candidate for advanced therapies like Deep Brain Stimulation?
  4. 4.Can you provide a referral to a Movement Disorder Specialist who offers telemedicine appointments in our state?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

What Are the Benefits of Boxing for Parkinson's Disease?Do All Parkinson's Patients Need a Wheelchair?Does Deep Brain Stimulation Slow Parkinson's Progression?Does Parkinson's Disease Affect Life Expectancy?Can I Get Focused Ultrasound Instead of DBS for Parkinson's?How Is Parkinson's Diagnosed vs. Essential Tremor?How Long Is the Parkinson's Disease Honeymoon Period?How to Take Levodopa with Protein Meals for Parkinson'sParkinson's Speech Therapy: Does It Help Hypophonia?Is Loss of Smell an Early Sign of Parkinson's Disease?Is Parkinson's Disease Genetic or Hereditary?Do Parkinson's Drugs Cause Impulse Control Disorders?Parkinson's Tremor vs Dyskinesia: What's the Difference?How Can You Sleep Safely with REM Sleep Behavior Disorder?What Causes Dizziness in Parkinson's Disease?Why Does Parkinson's Medication Wear Off?Tremor Dominant Parkinson's: How Fast Does It Progress?

References

References (21)
  1. 1

    Determining the impact of specialized care on health outcomes and health care utilization in Parkinsonism.

    Goerz CJ, Kanungo A, Lix LM, et al.

    Parkinsonism & related disorders 2024; (124()):106026 doi:10.1016/j.parkreldis.2024.106026.

    PMID: 38369425
  2. 2

    Should non-movement specialists refer patients for SPECT-DaTSCAN?

    Gajos A, Dąbrowski J, Bieńkiewicz M, et al.

    Neurologia i neurochirurgia polska 2019; (53(2)):138-143 doi:10.5603/PJNNS.a2019.0011.

    PMID: 30855703
  3. 3

    Teleneurology in Parkinson's disease: A step-by-step video guide.

    Ferreira D, Azevedo E, Araújo R

    Acta neurologica Scandinavica 2021; (144(2)):221-225 doi:10.1111/ane.13429.

    PMID: 33835482
  4. 4

    Linked Patient and Provider Impressions of Outpatient Teleneurology Encounters.

    James JG, Park J, Oliver A, et al.

    Neurology. Clinical practice 2023; (13(3)):e200159 doi:10.1212/CPJ.0000000000200159.

    PMID: 37153752
  5. 5

    Use of Complementary Health Approaches in Individuals With Parkinson's Disease.

    Shin JY, Pohlig RT, Habermann B

    Journal of gerontological nursing 2017; (43(2)):46-54 doi:10.3928/00989134-20161109-04.

    PMID: 27845808
  6. 6

    Machine Learning-Based Automatic Rating for Cardinal Symptoms of Parkinson Disease.

    Park KW, Lee EJ, Lee JS, et al.

    Neurology 2021; (96(13)):e1761-e1769 doi:10.1212/WNL.0000000000011654.

    PMID: 33568548
  7. 7

    Pearls & Oy-sters: Grisel Syndrome Presenting as Pseudodystonia: A Twist in the Neck.

    K P D, Cherian A

    Neurology 2022; (98(11)):462-465 doi:10.1212/WNL.0000000000200023.

    PMID: 35058340
  8. 8

    Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes.

    Houot M, Arnaud S, Mongin M, et al.

    Scientific reports 2024; (14(1)):25088 doi:10.1038/s41598-024-73777-y.

    PMID: 39443529
  9. 9

    Multiple system atrophy.

    Goh YY, Saunders E, Pavey S, et al.

    Practical neurology 2023; (23(3)):208-221 doi:10.1136/pn-2020-002797.

    PMID: 36927875
  10. 10

    A multidisciplinary telemedicine approach for managing frailty in Parkinson's disease. A longitudinal, case-control study.

    García-Bustillo Á, Ramírez-Sanz JM, Garrido-Labrador JL, et al.

    Parkinsonism & related disorders 2025; (130()):107215 doi:10.1016/j.parkreldis.2024.107215.

    PMID: 39586130
  11. 11

    IN-HOME-PD: The effects of longitudinal telehealth-enhanced interdisciplinary home visits on care and quality of life for homebound individuals with Parkinson's disease.

    Fleisher JE, Hess SP, Klostermann EC, et al.

    Parkinsonism & related disorders 2022; (102()):68-76 doi:10.1016/j.parkreldis.2022.07.017.

    PMID: 35963046
  12. 12

    European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies.

    Deuschl G, Antonini A, Costa J, et al.

    European journal of neurology 2022; (29(9)):2580-2595 doi:10.1111/ene.15386.

    PMID: 35791766
  13. 13

    Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.

    Dafsari HS, Ray-Chaudhuri K, Mahlstedt P, et al.

    European journal of neurology 2019; (26(2)):222-e17 doi:10.1111/ene.13773.

    PMID: 30107062
  14. 14

    [Adverse effects and complications of continuous intestinal infusion of levodopa-carbidopa in a cohort of patients with Parkinson's disease in a tertiary hospital].

    Campins-Romeu M, Sastre-Bataller I, Pons-Beltrán V, et al.

    Revista de neurologia 2022; (74(5)):143-148 doi:10.33588/rn.7405.2021482.

    PMID: 35211947
  15. 15

    Deep Brain Stimulation in Patients With Mutations in Parkinson's Disease-Related Genes: A Systematic Review.

    de Oliveira LM, Barbosa ER, Aquino CC, et al.

    Movement disorders clinical practice 2019; (6(5)):359-368 doi:10.1002/mdc3.12795.

    PMID: 31286005
  16. 16

    Ten-year trends of the characteristics in patients with advanced Parkinson's disease at the time of intestinal gel therapy introduction

    Szász JA, Szatmári S, Constantin V, et al.

    Orvosi hetilap 2022; (163(30)):1189-1195 doi:10.1556/650.2022.32534.

    PMID: 35895443
  17. 17

    European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.

    Deuschl G, Antonini A, Costa J, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(7)):1360-1374 doi:10.1002/mds.29066.

    PMID: 35791767
  18. 18

    A New Day: The Role of Telemedicine in Reshaping Care for Persons With Movement Disorders.

    Dorsey ER, Bloem BR, Okun MS

    Movement disorders : official journal of the Movement Disorder Society 2020; (35(11)):1897-1902 doi:10.1002/mds.28296.

    PMID: 32870517
  19. 19

    Current Status of Telemedicine for Parkinson's Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey.

    Ogawa M, Oyama G, Sekimoto S, et al.

    Journal of movement disorders 2022; (15(1)):58-61 doi:10.14802/jmd.21096.

    PMID: 34937160
  20. 20

    Telemedicine: A valuable tool in neurodegenerative diseases.

    Adams JL, Myers TL, Waddell EM, et al.

    Current geriatrics reports 2020; (9(2)):72-81 doi:10.1007/s13670-020-00311-z.

    PMID: 32509504
  21. 21

    Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease.

    Chepke C, Shaughnessy LW, Brunton S, et al.

    International journal of general medicine 2021; (14()):10271-10280 doi:10.2147/IJGM.S335739.

    PMID: 34992442

This information is for educational purposes and should not replace professional medical advice. Always consult your healthcare provider to determine the best care team and treatment plan for your Parkinson's disease.

Get notified when new evidence is published on Parkinson's Disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.